Sal003,
1164470-53-4,
Sal 003,
SMR000184519,
MLS000573670,
(E)-3-phenyl-N-[2,2,2-trichloro-1-[(4-chlorophenyl)carbamothioylamino]ethyl]prop-2-enamide,
3-PHENYL-N-(2,2,2-TRICHLORO-1-((((4-CHLOROPHENYL)AMINO)CARBONOTHIOYL)AMINO)ETHYL)ACRYLAMIDE,
3-phenyl-N-[2,2,2-trichloro-1-({[(4-chlorophenyl)amino]carbonothioyl}amino)ethyl]acrylamide,
(2E)-3-phenyl-N-(2,2,2-trichloro-1-{[(4-chlorophenyl)carbamothioyl]amino}ethyl)prop-2-enamide,
(2E)-3-Phenyl-N-[2,2,2-trichloro-1-[[[(4-chlorophenyl)amino]thioxomethyl]amino]ethyl]-2-propenamide,
eIF-2alpha Inhibitor II, Sal003,
AC1NX19J,
CHEMBL1340458,
SCHEMBL17748150,
BDBM57469,
cid_5717737,
AOB6818,
HMS2374J18,
HMS3678E09,
eIF-2|A Inhibitor II, Sal003,
BCP08928,
EX-A2152,
2698AH,
MFCD00361095,
s7437,
STL253109,
AKOS002338493,
AKOS016336084,
API0008274,
CS-4190,
eIF-2(c) paragraph sign Inhibitor II,
Sal003, >=98% (HPLC),
3--Phenyl-N-(2,2,2-trichloro-1-((((4-chlorophenyl)amino)carbonothioyl)amino)ethyl)acrylamide,
BC600423,
DA-47669,
HY-15969,
RT-017352,
J-003440,
(E)-1-(4-chlorophenyl)-3-(1,1,1-trichloro-4-oxo-6-phenylhex-5-en-2-yl)thiourea,
(E)-3-phenyl-N-[2,2,2-trichloro-1-[(4-chlorophenyl)thiocarbamoylamino]ethyl]acrylamide,
(E)-3-phenyl-N-[2,2,2-trichloro-1-[[(4-chloroanilino)-sulfanylidenemethyl]amino]ethyl]-2-propenamide,
(E)-3-phenyl-N-[2,2,2-tris(chloranyl)-1-[(4-chlorophenyl)carbamothioylamino]ethyl]prop-2-enamide,
2-Propenamide, 3-phenyl-N-[2,2,2-trichloro-1-[[[(4-chlorophenyl)amino]thioxomethyl]amino]ethyl]-, (2E)-,
Sirtinol,
C18H15Cl4N3OS,
TVNBASWNLOIQML-IZZDOVSWSA-N,
CID5717737,
A4541,
410536-97-9,